循环微生物游离DNA测序可识别假体周围关节感染病原体
这项前瞻性观察研究纳入53例确诊髋或膝关节假体周围感染成人,术前采外周血行微生物游离DNA测序,与术中组织及关节液培养比较。cfDNA测序在35例中识别出关节病原体,包括7例培养阴性中的4例,作为培养补充将病原体检出率从87%提高至94%。
要点
- 术前外周血微生物cfDNA测序可无创识别假体周围关节感染病原体。
- 作为培养补充,cfDNA测序将病原体检出率从87%提高至94%。
- 培养仅鉴定到属时,cfDNA测序物种鉴定中位时间缩短3天。
核心结论
- 导致局部假体周围关节感染的病原体微生物cfDNA可在外周血中检测到,并可通过非侵入性静脉穿刺测序,为关节病原体鉴定提供新来源。
研究设计与样本
- 在美国一家肌肉骨骼专科医院开展的前瞻性观察研究,纳入53例确诊髋或膝关节假体周围感染的成人,术前采外周血行血浆微生物cfDNA测序并与术中组织及关节液培养比较。
主要发现
- 术中及术前关节培养在53例中的46例(87%)鉴定出病原体。
- 微生物cfDNA测序在35例中识别出关节病原体,包括7例培养阴性中的4例(57%)。
- 作为培养补充,cfDNA测序将病原体检出率从87%提高至94%。
- 培养仅鉴定到属的病例中,cfDNA测序物种鉴定中位时间比标准方法缩短3天。
- 14例中循环cfDNA测序检出培养未生长的额外微生物;术后随访时cfDNA测序未检出或水平降低。
临床怎么用
- 可将术前外周血微生物cfDNA测序作为组织培养的补充,以提高假体周围关节感染病原体鉴定率并缩短物种鉴定时间。
- 该检测或可作为治疗期间监测感染清除的新方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Over 1 million Americans undergo joint replacement each year, and approximately 1 in 75 will incur a periprosthetic joint infection. Effective treatment necessitates pathogen identification, yet standard-of-care cultures fail to detect organisms in 10% to 20% of cases and require invasive sampling. We hypothesized that cell-free DNA (cfDNA) fragments from microorganisms in a periprosthetic joint infection can be found in the bloodstream and utilized to accurately identify pathogens via next-generation sequencing. METHODS: In this prospective observational study performed at a musculoskeletal specialty hospital in the U.S., we enrolled 53 adults with validated hip or knee periprosthetic joint infections. Participants had peripheral blood drawn immediately prior to surgical treatment. Microbial cfDNA from plasma was sequenced and aligned to a genome database with >1,000 microbial species. Intraoperative tissue and synovial fluid cultures were performed per the standard of care. The primary outcome was accuracy in organism identification with use of blood cfDNA sequencing, as measured by agreement with tissue-culture results. RESULTS: Intraoperative and preoperative joint cultures identified an organism in 46 (87%) of 53 patients. Microbial cfDNA sequencing identified the joint pathogen in 35 cases, including 4 of 7 culture-negative cases (57%). Thus, as an adjunct to cultures, cfDNA sequencing increased pathogen detection from 87% to 94%. The median time to species identification for cases with genus-only culture results was 3 days less than standard-of-care methods. Circulating cfDNA sequencing in 14 cases detected additional microorganisms not grown in cultures. At postoperative encounters, cfDNA sequencing demonstrated no detection or reduced levels of the infectious pathogen. CONCLUSIONS: Microbial cfDNA from pathogens causing local periprosthetic joint infections can be detected in peripheral blood. These circulating biomarkers can be sequenced from noninvasive venipuncture, providing a novel source for joint pathogen identification. Further development as an adjunct to tissue cultures holds promise to increase the number of cases with accurate pathogen identification and improve time-to-speciation. This test may also offer a novel method to monitor infection clearance during the treatment period. LEVEL OF EVIDENCE: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Echeverria AP, Cohn IS, Danko DC, et al. Sequencing of Circulating Microbial Cell-Free DNA Can Identify Pathogens in Periprosthetic Joint Infections. J Bone Joint Surg Am. 2021. PMID: 34293751. doi:10.2106/JBJS.20.02229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。